Oncogene - Table of Contents alert Volume 32 Issue 22

Advertisement Think ChIP is hard? We make it easy! Diagenode provides ChIP, ChIP-seq, and DNA methylation solutions making epigenetics research easy and accessible. Eliminate the challenges of your epigenetics workflow with thoroughly validated antibodies, epigenetic kits, Bioruptor chromatin and DNA shearing systems, and our unique ChIP/ChIP-seq automation system. Learn more. TABLE OF CONTENTS Volume 32, Issue 22 (May 2013) In this issue Review Commentary Original Articles Short Communications Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Central roles of apoptotic proteins in mitochondrial function S M Kilbride and J H M Prehn Oncogene 2013 32: 2703-2711; advance online publication, August 6, 2012; 10.1038/onc.2012.348 Abstract | Full Text Commentary Top BRCA1 mutations and luminal-basal transformation T Ng, S Irshad and J Stebbing Oncogene 2013 32: 2712-2714; advance online publication, August 27, 2012; 10.1038/onc.2012.379 Abstract | Full Text Original Articles Top Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation F Bai, M D Smith, H L Chan and X-H Pei Oncogene 2013 32: 2715-2725; advance online publication, July 9, 2012; 10.1038/onc.2012.293 Abstract | Full Text CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model Y Ward, R Lake, P L Martin, K Killian, P Salerno, T Wang, P Meltzer, M Merino, S-y Cheng, M Santoro, G Garcia-Rostan and K Kelly Oncogene 2013 32: 2726-2738; advance online publication, July 16, 2012; 10.1038/onc.2012.301 Abstract | Full Text Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation B A Benayoun, M Anttonen, D L’Hôte, M Bailly-Bechet, N Andersson, M Heikinheimo and R A Veitia Oncogene 2013 32: 2739-2746; advance online publication, July 16, 2012; 10.1038/onc.2012.298 Abstract | Full Text Leukemia cell to endothelial cell communication via exosomal miRNAs T Umezu, K Ohyashiki, M Kuroda and J H Ohyashiki Oncogene 2013 32: 2747-2755; advance online publication, July 16, 2012; 10.1038/onc.2012.295 Abstract | Full Text Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways Y Pan, Q Zhang, V Atsaves, H Yang and F X Claret Oncogene 2013 32: 2756-2766; advance online publication, July 16, 2012; 10.1038/onc.2012.294 Abstract | Full Text c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling W K Chau, C K Ip, A S C Mak, H-C Lai and A S T Wong Oncogene 2013 32: 2767-2781; advance online publication, July 16, 2012; 10.1038/onc.2012.290 Abstract | Full Text Identification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop X Zhang, W Wang, H Wang, M-H Wang, W Xu and R Zhang Oncogene 2013 32: 2782-2791; advance online publication, July 9, 2012; 10.1038/onc.2012.289 Abstract | Full Text Short Communications Top Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence Y Tang, I Horikawa, M Ajiro, A I Robles, K Fujita, A M Mondal, J K Stauffer, Z-M Zheng and C C Harris Oncogene 2013 32: 2792-2798; advance online publication, July 9, 2012; 10.1038/onc.2012.288 Abstract | Full Text Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling K Brennan, E A McSherry, L Hudson, E W Kay, A D K Hill, L S Young and A M Hopkins Oncogene 2013 32: 2799-2804; advance online publication, July 2, 2012; 10.1038/onc.2012.276 Abstract | Full Text Advertisement Nature Reviews Cancer ARTICLE SERIES ON CANCER CELL BIOLOGY Understanding how the deregulation of normal cell biological processes leads to malignant transformation and cancer progression is a major area of research. Nature Cell Biology brings a series of specially commissioned pieces discussing current topics and recent advances in this field. Read the April article for FREE. Discussing the cancer stem cell concept Jan Paul Medema www.nature.com/ncb/journal/v15/n4/full/ncb2717.html   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.